| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.10541 |
| P8608 | Fatcat ID | release_o5657ber6zfrpdneslojs2cefu |
| P698 | PubMed publication ID | 12173339 |
| P5875 | ResearchGate publication ID | 227627421 |
| P50 | author | Leo J Schouten | Q67234425 |
| P2093 | author name string | Joost Rutten | |
| Albert Twijnstra | |||
| Hans A M Huveneers | |||
| P2860 | cites work | Risk and patterns of brain metastases in colorectal cancer: 27-year experience | Q33776269 |
| The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors | Q37976168 | ||
| Cancer of the colon, rectum and anus: review of 1,687 cases | Q40071225 | ||
| Cerebral metastases from lung carcinoma: neurological and CT correlation. Work in progress | Q40078561 | ||
| High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma. | Q40482175 | ||
| Metastatic patterns of renal carcinoma: an analysis of 687 necropsies | Q41407886 | ||
| Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. | Q41675125 | ||
| Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: Correlation with survival | Q44304690 | ||
| Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis | Q44493823 | ||
| The Neuro-Oncology Register. | Q44595153 | ||
| Clinical study of brain metastasis of renal cell carcinoma | Q48134243 | ||
| Brain metastasis in hypernephroma | Q48229597 | ||
| Clinical study of renal cell carcinoma with brain metastasis | Q48484336 | ||
| Proceedings: Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma | Q48582396 | ||
| Central nervous system metastasis from breast carcinoma. Autopsy study | Q48704506 | ||
| Brain metastases from colon cancer | Q48818963 | ||
| Brain metastasis in the natural history of small-cell lung cancer 1972–1979 | Q48910543 | ||
| Colorectal carcinoma and brain metastasis: distribution, treatment, and survival | Q48930995 | ||
| Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. | Q50994497 | ||
| Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. | Q51046360 | ||
| Distribution of distant metastases from newly diagnosed non-small cell lung cancer. | Q52302957 | ||
| Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis | Q70211565 | ||
| Intracerebral metastases in solid-tumor patients: Natural history and results of treatment | Q70789624 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 2698-2705 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma | |
| P478 | volume | 94 |
| Q37393050 | "Unsteady gait": an uncommon presentation and course of malignant melanoma in terminal ileum-a case report and review of literature |
| Q90386370 | 90-gene signature assay for tissue origin diagnosis of brain metastases |
| Q52717598 | A Comparative Review of Demographics, Incidence, and Epidemiology of Histologically Confirmed Intracranial Tumors in Brazil and Bulgaria. |
| Q47739279 | A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models |
| Q39192764 | A cancer stem cell model for studying brain metastases from primary lung cancer |
| Q36122488 | A case-matched study of stereotactic radiosurgery for patients with brain metastases: comparing treatment results for those with versus without neurological symptoms |
| Q33860823 | A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancer |
| Q37087347 | A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320 |
| Q34000987 | A review of current management of brain metastases |
| Q35537937 | ACTN4 and the pathways associated with cell motility and adhesion contribute to the process of lung cancer metastasis to the brain |
| Q34497467 | AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients |
| Q94401599 | Advances in Imaging: Brain Tumors to Alzheimer's Disease |
| Q39016244 | Advances in decoding breast cancer brain metastasis |
| Q27022452 | Advances in treatment of brain metastases from primary non-small cell lung cancer |
| Q35182207 | An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer |
| Q42824566 | An experimental study on the Chinese lung adenocarcinoma cell clone CPA-Yang1-BR with brain metastasis potency in nude mice and in vivo imaging research |
| Q36538454 | An institutional retrospective analysis of 93 patients with brain metastases from breast cancer: treatment outcomes, diagnosis-specific prognostic factors. |
| Q37724215 | Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability |
| Q46207104 | Are melanomas averse to cerebellum? Cerebellar metastases in a surgical series |
| Q36341131 | Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations |
| Q48632565 | Attributes of brain metastases from breast and lung cancer |
| Q30691203 | Atypical MRI findings of synchronous cerebral metastasis. A case report and literature review |
| Q39750563 | BRAF Mutation Is Associated with Improved Local Control of Melanoma Brain Metastases Treated with Gamma Knife Radiosurgery. |
| Q57176317 | Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine |
| Q40161173 | Bevacizumab in Combination with Chemotherapy for Colorectal Brain Metastasis |
| Q92373380 | Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases |
| Q24568071 | Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies |
| Q92637436 | Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC |
| Q36803966 | Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer |
| Q48645962 | Brain Metastases from Different Primary Carcinomas: an Evaluation of DSC MRI Measurements |
| Q89861115 | Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers |
| Q38903136 | Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. |
| Q79969979 | Brain metastases |
| Q83839473 | Brain metastases |
| Q84595953 | Brain metastases |
| Q37457725 | Brain metastases admissions in Sweden between 1987 and 2006 |
| Q57982029 | Brain metastases as the first sign of colon cancer |
| Q54364568 | Brain metastases exhibit gross deletions of the APC gene. |
| Q37540024 | Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. |
| Q34018126 | Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center |
| Q33577959 | Brain metastases from colorectal carcinoma: prognostic factors and outcome. |
| Q35864062 | Brain metastases from endometrial carcinoma |
| Q35608948 | Brain metastases from ovarian carcinoma |
| Q38066590 | Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario. |
| Q48101088 | Brain metastases in colorectal cancer. |
| Q37385876 | Brain metastases in colorectal cancers |
| Q38233149 | Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches |
| Q92134610 | Brain metastases in oncogene-driven non-small cell lung cancer |
| Q48484623 | Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19). |
| Q36741681 | Brain metastases management paradigm shift: A case report and review of the literature. |
| Q39649086 | Brain metastases of mouse mammary adenocarcinoma is increased by acute stress |
| Q36282137 | Brain metastases: epidemiology and pathophysiology. |
| Q58608725 | Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features |
| Q80447187 | Brain metastasis from colorectal cancer |
| Q48685830 | Brain metastasis from colorectal cancer: prognostic factors and survival |
| Q38913258 | Brain metastasis in lung cancer: Building a molecular and systems-level understanding to improve outcomes |
| Q61809451 | Brain metastasis in pancreatic cancer: Two case reports |
| Q37559001 | Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression |
| Q28078998 | Breast cancer brain metastases: biology and new clinical perspectives |
| Q36853533 | CNS complications of breast cancer: current and emerging treatment options |
| Q37779510 | Cancer pain emergencies: is there a role for radiation therapy? |
| Q91810888 | Caveolin-1 enhances brain metastasis of non-small cell lung cancer, potentially in association with the epithelial-mesenchymal transition marker SNAIL |
| Q58578661 | Cavity volume changes after surgery of a brain metastasis-consequences for stereotactic radiation therapy |
| Q34014740 | Central nervous system cancers |
| Q35112006 | Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines |
| Q57642646 | Cerebral staging of lung cancer: is one single contrast-enhanced T1-weighted three-dimensional gradient-echo sequence sufficient? |
| Q37845206 | Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy. |
| Q35078652 | Characteristics of long-term survivors of brain metastases from lung cancer |
| Q36804855 | Characterization of the melanoma brain metastatic niche in mice and humans |
| Q34969177 | Chemotherapy for the treatment of metastatic brain tumors |
| Q58297721 | Chemotherapy in brain metastases of lung and breast cancer |
| Q40372968 | China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version) |
| Q104617791 | Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis |
| Q50050455 | Classification and regression tree analysis of patients with non-small-cell lung cancer treated with gefitinib after chemotherapy |
| Q48091576 | Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis |
| Q37112587 | Clinical Outcomes of Gamma Knife Radiosurgery for Metastatic Brain Tumors from Gynecologic Cancer : Prognostic Factors in Local Treatment Failure and Survival |
| Q37677555 | Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience |
| Q99609719 | Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up? |
| Q33396965 | Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib |
| Q36278551 | Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution |
| Q97524996 | Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma |
| Q33249084 | Clinical management of women with metastatic breast cancer: a descriptive study according to age group. |
| Q90128600 | Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 years |
| Q48300984 | Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial). |
| Q26778009 | Colorectal cancer: Metastases to a single organ |
| Q36684011 | Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis |
| Q33418225 | Comparison of Gefitinib versus VMP in the combination with radiotherapy for multiple brain metastases from non-small cell lung cancer |
| Q59103143 | Contemporary Review of the Management of Brain Metastasis with Radiation |
| Q47825143 | Contraction of T cell richness in lung cancer brain metastases. |
| Q38511670 | Control of the blood-brain barrier function in cancer cell metastasis |
| Q38905543 | Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship |
| Q35705221 | Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy |
| Q47935277 | Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China |
| Q48306984 | Cranial metastases: first sign of colorectal cancer. Is the resection of the primary non-complicated tumour indicated when the metastases have been resected? |
| Q89811416 | Current approaches to the management of brain metastases |
| Q33696559 | Current approaches to the treatment of metastatic brain tumours |
| Q42369337 | Current evidence in support of the second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor alectinib for the treatment of non-small cell lung cancer positive for ALK translocation |
| Q35687738 | Current standards in the management of cerebral metastases |
| Q90291777 | Current state of clinical trials in breast cancer brain metastases |
| Q88671517 | CyberKnife Stereotactic Radiosurgery in brain metastases: A report from Latin America with literature review |
| Q33529158 | DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis |
| Q56673276 | Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter |
| Q48165318 | Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients. |
| Q58695716 | Delayed brain metastasis from renal cell carcinoma |
| Q41698977 | Demographics and Incidence of Histologically Confirmed Intracranial Tumors: A Five-year, Two-center Prospective Study. |
| Q40382284 | Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab |
| Q50772691 | Diagnosis of Brain Metastases from Lung Cancer Using a Modified Electromagnetism like Mechanism Algorithm. |
| Q49080799 | Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer |
| Q37211899 | Diagnostic segregation of human brain tumours using Fourier-transform infrared and/or Raman spectroscopy coupled with discriminant analysis |
| Q40253869 | Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells |
| Q48701324 | Distinct genetic profiles of extracranial and intracranial acral melanoma metastases. |
| Q38718141 | Docosahexaenoic acid-mediated, targeted and sustained brain delivery of curcumin microemulsion |
| Q33386298 | Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. |
| Q48723375 | Dosimetric comparison of volumetric modulated arc therapy and linear accelerator-based radiosurgery for the treatment of one to four brain metastases |
| Q37288557 | Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases |
| Q41502662 | Drainage after Modified Radical Mastectomy - A Methodological Mini-Review. |
| Q92159112 | EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis |
| Q39595689 | Early start of chemotherapy after resection of brain metastasis from colon cancer with synchronous multiple liver metastases. |
| Q57598537 | Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases |
| Q44531462 | Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells |
| Q38616077 | Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer |
| Q34774082 | Efficacy of surgical treatment for brain metastasis in patients with non-small cell lung cancer |
| Q37356182 | Emerging role of brain metastases in the prognosis of breast cancer patients |
| Q58106214 | Enrichment of Amplification in Brain Metastases from Primary Gastrointestinal Malignancies |
| Q89445493 | Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells |
| Q40282281 | Epidemiology of Intracranial Metastases in Korea: A National Cohort Investigation. |
| Q37812444 | Epidemiology of Metastatic Brain Tumors |
| Q48829653 | Epidemiology of brain metastases |
| Q94503874 | Epidemiology of synchronous brain metastases |
| Q58608173 | Epigenetic profiling for the molecular classification of metastatic brain tumors |
| Q36546293 | Epigenetic silencing of miR-145-5p contributes to brain metastasis |
| Q58585887 | Epithelial Ovarian Carcinoma Associated with Metastases to Central Nervous System: Two Case Reports |
| Q93003245 | Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool |
| Q38752195 | Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study. |
| Q58037620 | Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies |
| Q33852867 | Evaluation of clinical contributions provided by addition of the brain, calvarium, and scalp to the limited whole body imaging area in FDG-PET/CT tumor imaging |
| Q48331662 | Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases. |
| Q64100558 | Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature review |
| Q48128817 | Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer |
| Q87559519 | Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis |
| Q47143720 | Fractionated stereotactic radiation therapy for intact brain metastases |
| Q53058112 | Freiburg neuropathology case conference: tumor of the cerebellum with mild, gyriform enhancement in a 19-year-old patient. |
| Q38110294 | Future directions in treatment of brain metastases |
| Q46209961 | Gamma knife radiosurgery for brainstem metastases: the UCSF experience |
| Q30458897 | Gamma knife radiosurgery for the treatment of gynecologic malignancies metastasizing to the brain: clinical article |
| Q83694794 | Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer |
| Q91740465 | Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036) |
| Q41032563 | Genetic variants associated with colorectal brain metastases susceptibility and survival. |
| Q36851190 | Gliadel for brain metastasis. |
| Q37603636 | High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases |
| Q42215312 | High-grade Gliomas Exhibit Higher Peritumoral Fractional Anisotropy and Lower Mean Diffusivity than Intracranial Metastases |
| Q48369246 | Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation. |
| Q47325224 | IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes. |
| Q37121543 | Icotinib combined whole brain radiotherapy for patients with brain metastasis from lung adenocarcinoma harboring epidermal growth factor receptor mutation |
| Q33553971 | Identification of breast cancer patients with a high risk of developing brain metastases: a single-institutional retrospective analysis. |
| Q33862844 | Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice |
| Q93088315 | Immune Microenvironment of Brain Metastases-Are Microglia and Other Brain Macrophages Little Helpers? |
| Q38829087 | Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine. |
| Q92326302 | Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice |
| Q99590141 | Impact of Systemic Therapy Type and Timing on Intracranial Tumor Control in Patients with Brain Metastasis from Non-Small Cell Lung Cancer Treated With Stereotactic Radiosurgery |
| Q39476399 | Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma |
| Q90410649 | Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases |
| Q38819317 | Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: A population-based study |
| Q35998465 | Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden |
| Q37542524 | Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer |
| Q35788710 | Incidence of brain metastasis at initial presentation of lung cancer |
| Q39770910 | Inclusion of brain in FDG PET/CT scanning techniques in cancer patients: Does it obviate the need for dedicated brain imaging? |
| Q88380515 | Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy |
| Q36908901 | Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade |
| Q36322851 | Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary? |
| Q34388791 | Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis |
| Q48266491 | Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis |
| Q45222017 | Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain. |
| Q38005011 | Intracranial hemorrhage in patients with cancer. |
| Q31133294 | Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging |
| Q53610573 | Investigating the causes of vertigo in breast cancer survivors. |
| Q43205053 | Is Karnofsky Performance Status Correlate with Better Overall Survival in Palliative Conformal Whole Brain Radiotherapy? Our Experience |
| Q41954795 | Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer? |
| Q37002744 | Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer |
| Q64119979 | LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway |
| Q35605403 | Long-term survival in patients with non-small cell lung cancer and synchronous brain metastasis treated with whole-brain radiotherapy and thoracic chemoradiation |
| Q52715757 | Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited. |
| Q34701110 | Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model |
| Q38970551 | MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases |
| Q29248327 | MRI Virtual Biopsy and Treatment of Brain Metastatic Tumors with Targeted Nanobioconjugates: Nanoclinic in the Brain |
| Q37439481 | Management of brain metastases: the indispensable role of surgery |
| Q41242405 | Management of metastatic renal cell carcinoma in patients with poor prognosis. |
| Q91675162 | Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions |
| Q46237859 | Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries |
| Q89741955 | Mapping distribution of brain metastases: does the primary tumor matter? |
| Q38987554 | Means to the ends: The role of telomeres and telomere processing machinery in metastasis |
| Q26995622 | Melanoma brain metastases: an unmet challenge in the era of active therapy |
| Q38053444 | Melanoma brain metastasis: overview of current management and emerging targeted therapies. |
| Q34639617 | Metastasectomy for renal cell cancer |
| Q30684585 | Metastasis to the choroid plexus from thyroid cancer: case report. |
| Q38709959 | Metastatic Gastrointestinal Stromal Tumor to the Skull |
| Q48368625 | Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade. |
| Q42406088 | Metastatic malignant melanoma intraoperative imprint cytology of brain tumor |
| Q58734063 | MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology |
| Q38219675 | MicroRNAs in brain metastases: potential role as diagnostics and therapeutics. |
| Q37892462 | Modern management of rare brain metastases in adults. |
| Q33367980 | Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery |
| Q36261926 | Multidrug resistance protein and topoisomerase 2 alpha expression in non-small cell lung cancer are related with brain metastasis postoperatively |
| Q41140382 | Mutations targeting the coagulation pathway are enriched in brain metastases. |
| Q34104503 | Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents |
| Q39330269 | Nanotherapeutic systems for local treatment of brain tumors |
| Q97652827 | Nephronectin promotes breast cancer brain metastatic colonization via its integrin-binding domains |
| Q35125199 | Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases |
| Q36618258 | Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study |
| Q41364500 | Neurological symptoms from a brain metastasis as the first presentation of colorectal cancer |
| Q37303869 | New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer |
| Q52727330 | Non-small-cell Lung Cancer With Brain Metastasis at Presentation. |
| Q34631769 | Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment |
| Q90376945 | Operative and peri-operative considerations in the management of brain metastasis |
| Q38991958 | Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience |
| Q38376086 | Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy |
| Q38807704 | Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases |
| Q99402866 | Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours |
| Q89964967 | PET/MRI Radiomics in Patients With Brain Metastases |
| Q40362736 | Patent foramen ovale as a preferential mechanism for increasing the likelihood of brain tumor metastasis. |
| Q37732294 | Patient-based strategy for systemic treatment of metastatic renal cell carcinoma |
| Q35000133 | Patients undergoing surgery of intracranial metastases have different outcomes based on their primary pathology |
| Q35700728 | Patients with brain metastases derived from gastrointestinal cancer: clinical characteristics and prognostic factors |
| Q34674089 | Pattern of distant metastases in colorectal cancer: a SEER based study |
| Q28072442 | Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases |
| Q26825116 | Pituitary gland metastasis from rectal cancer: report of a case and literature review |
| Q86586308 | Pituitary metastasis of colon adenocarcinoma: a rare occurrence |
| Q38216682 | Pituitary metastasis of rhabdomyosarcoma: a case report and review of the literature |
| Q48134424 | Polymeric Micelle of A₃B-Type Lactosome as a Vehicle for Targeting Meningeal Dissemination |
| Q44375821 | Pontine metastases as a cause of dysphagia in lung carcinoma |
| Q89210731 | Posterior Fossa Metastasis-Associated Obstructive Hydrocephalus in Adult Patients: Literature Review and Practical Considerations from the Neuro-Oncology Club of the French Society of Neurosurgery |
| Q47912196 | Postoperative radiosurgery for the treatment of metastatic brain tumor: Evaluation of local failure and leptomeningeal disease |
| Q55345918 | Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis. |
| Q90396417 | Preoperative brain MRI for clinical stage IA lung cancer: is routine scanning rational? |
| Q30587443 | Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times |
| Q89414837 | Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors |
| Q30847702 | Prevalence of detecting unknown cerebral metastases in fluorodeoxyglucose positron emission tomography/computed tomography and its potential clinical impact |
| Q35646869 | Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations |
| Q50050567 | Prognosis for non-small cell lung cancer patients with brain metastases |
| Q38731958 | Prognostic factors for patients with brain metastasis from gynecological cancer: a significance of treatment-free interval of more than 6 months |
| Q90171081 | Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study |
| Q92318252 | Prognostic factors of brain metastases from colorectal cancer |
| Q58556208 | Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases |
| Q89183951 | Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study |
| Q42861900 | Progression of intramedullary metastasis during perioperative cessation of sunitinib |
| Q38416214 | Prophylactic cranial irradiation in non-small cell lung cancer patients: who might be the candidates? |
| Q54982136 | Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases. |
| Q37454266 | Quality of life and radiotherapy in brain metastasis patients |
| Q33574565 | Radiation therapy for brain metastases in breast cancer patients |
| Q89534129 | Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery |
| Q33532191 | Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients. |
| Q34105366 | Reactive Astrocytes Protect Melanoma Cells from Chemotherapy by Sequestering Intracellular Calcium through Gap Junction Communication Channels |
| Q37346039 | Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors |
| Q48279253 | Reduced mRNA and protein expression of BCL-2 versus decreased mRNA and increased protein expression of BAX in breast cancer brain metastases: a real-time PCR and immunohistochemical evaluation |
| Q33658254 | Reference Data for Standardized Quality of Life Questionnaires in Indian Patients with Brain Metastases from Non-small Cell Lung Cancer: Results from a Prospective Study |
| Q36245550 | Relevance of PTEN loss in brain metastasis formation in breast cancer patients |
| Q36406703 | Remote multiple intracranial hemorrhage in multiple metastatic lung adenocarcinoma following decompression of posterior fossa lesion: Unknown cause |
| Q37229365 | Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature. |
| Q55265338 | Repeated Stereotactic Radiosurgery in Brain Metastases: A Case Report. |
| Q47338093 | Report of a male patient with brain metastases from breast cancer |
| Q53216873 | Respiratory-induced prostate motion: characterization and quantification in dynamic MRI. |
| Q33222212 | Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis |
| Q43532193 | Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival |
| Q90700006 | Risk Factors for Brain Metastases in Patients with Renal Cell Carcinoma |
| Q58577411 | Risk factors for brain metastases in patients with non-small-cell lung cancer |
| Q36198417 | Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer |
| Q91638768 | Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis |
| Q31072630 | Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data |
| Q42611535 | Role for catecholamines in tumor progression: possible use for β-blockers in the treatment of cancer |
| Q34513604 | Role of efaproxiral in metastatic brain tumors |
| Q98613555 | Role of imaging biomarkers in mutation-driven non-small cell lung cancer |
| Q39485951 | S100B promotes the proliferation, migration and invasion of specific brain metastatic lung adenocarcinoma cell line |
| Q35757920 | STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation. |
| Q37284300 | Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases |
| Q48110999 | Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases |
| Q36428221 | Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA). |
| Q38110297 | Seed, soil, and beyond: The basic biology of brain metastasis |
| Q92132955 | Single Solitary Fibrous Tumor Brain Metastasis in a Patient with Simultaneous Adenocarcinoma of the Lung: Case Report and Review of the Literature |
| Q47156351 | Single fraction stereotactic radiosurgery for multiple brain metastases |
| Q54942435 | Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions. |
| Q37586254 | Strategy of surgery and radiation therapy for brain metastases |
| Q26743618 | Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review |
| Q81169735 | Surgical treatment for brain metastases: prognostic factors and survival in 177 patients |
| Q51735296 | Suspected brain metastasis from lung cancer mimicking intracerebral hemorrhage: A case report. |
| Q28066158 | Systematic review: brain metastases from colorectal cancer--Incidence and patient characteristics |
| Q92255269 | Systemic therapy for brain metastases |
| Q30239901 | Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma |
| Q27322618 | TNF-α enhancement of CD62E mediates adhesion of non-small cell lung cancer cells to brain endothelium via CD15 in lung-brain metastasis |
| Q39192200 | Targeted Treatment of Brain Metastases |
| Q30474781 | Targeted drug delivery across the blood-brain barrier using ultrasound technique |
| Q49956245 | Targeted therapy of brain metastases: latest evidence and clinical implications |
| Q92219274 | The Choice of Local Treatment Modalities for Patients with Brain Metastases from Digestive Cancers |
| Q90113096 | The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review |
| Q52673453 | The Evolving Landscape of Brain Metastasis. |
| Q58779547 | The Expanding Role of Radiosurgery for Brain Metastases |
| Q36243003 | The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery |
| Q37053619 | The benefit of whole brain reirradiation in patients with multiple brain metastases |
| Q35676602 | The biology of brain metastases-translation to new therapies |
| Q35000396 | The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns |
| Q38564085 | The future of targeted therapies for brain metastases |
| Q37586262 | The role of chemotherapy in the treatment of patients with brain metastases from solid tumors |
| Q36293547 | The role of radiosurgery in the management of malignant brain tumors. |
| Q64985045 | Therapeutical Attitude and Analysis of Results in Brain Metastases. |
| Q30557877 | Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data |
| Q36106920 | Treating brain metastases: current approaches and future directions |
| Q38646117 | Treatment of Melanoma CNS Metastases |
| Q38293247 | Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature |
| Q38139324 | Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy |
| Q37967507 | Treatment of brain metastases: chemotherapy |
| Q59872738 | Treatment of brain metastasis from lung cancer |
| Q35721994 | Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters |
| Q38611425 | Two-year experience of multi-disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre |
| Q36587552 | Ubiquitin-specific protease 4 controls metastatic potential through β-catenin stabilization in brain metastatic lung adenocarcinoma |
| Q34083162 | Ultrasound imaging-guided intracardiac injection to develop a mouse model of breast cancer brain metastases followed by longitudinal MRI. |
| Q48341658 | Uterine cervical cancer with brain metastasis as the initial site of presentation |
| Q33475683 | Utility of administrative claims data for the study of brain metastases: a validation study |
| Q37398492 | Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases |
| Q48063744 | Validation of the Brain Symptom and Impact Questionnaire (BASIQ) to assess symptom and quality of life in brain metastases |
| Q38066701 | Value of 11C-methionine PET in imaging brain tumours and metastases |
| Q36472566 | Vemurafenib and concomitant stereotactic radiation for the treatment of melanoma with spinal metastases: A case report |
| Q54988853 | What Do Germans Want to Know About Skin Cancer? A Nationwide Google Search Analysis From 2013 to 2017. |
| Q90657515 | Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study |
| Q34347439 | Whole brain radiotherapy for brain metastasis |
| Q54546638 | [Complete remission of multiple brain metastases of non-small cell lung cancer induced by gefitinib monotherapy]. |
| Q88803135 | [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist] |
| Q53026589 | [Prognostic biomarkers for metastatic colorectal cancer]. |
| Q83367204 | [Radiotherapy of singular brain metastases] |
| Q53470867 | [Silent brain metastasis in the initial staging of lung cancer: evaluation by computed tomography and magnetic resonance imaging]. |
| Q80703051 | [Stage IIIA and IIIB non-small cell lung cancer: results of chemotherapy combined with radiation therapy and analysis of prognostic factors] |
| Q53413935 | miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers. |
Search more.